{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:47:17Z","timestamp":1787856437116,"version":"build-2784847793"},"reference-count":120,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":1361,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Asmarley Charitable Trust"},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT096964MA"],"award-info":[{"award-number":["WT096964MA"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Asmarley Charitable Trust"},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT096964MA"],"award-info":[{"award-number":["WT096964MA"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A dramatic global reduction in the incidence of common seasonal respiratory viral infections has resulted from measures to limit the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the pandemic. This has been accompanied by falls reaching 50% internationally in the incidence of acute exacerbations of preexisting chronic respiratory diseases that include asthma, chronic obstructive pulmonary disease, and cystic fibrosis. At the same time, the incidence of acute bacterial pneumonia and sepsis has fallen steeply worldwide. Such findings demonstrate the profound impact of common respiratory viruses on the course of these global illnesses. Reduced transmission of common respiratory bacterial pathogens and their interactions with viruses appear also as central factors. This review summarizes pandemic changes in exacerbation rates of asthma, chronic obstructive pulmonary disease, cystic fibrosis, and pneumonia. We draw attention to the substantial body of knowledge about respiratory virus infections in these conditions, and that it has not yet translated into clinical practice. Now that the large scale of benefits that could be gained by managing these pathogens is unmistakable, we suggest that the field merits substantial academic and industrial investment. We consider how pandemic-inspired measures for prevention and treatment of common infections should become a cornerstone for managing respiratory diseases.<\/jats:p>","DOI":"10.1164\/rccm.202110-2389ci","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T14:44:36Z","timestamp":1645541076000},"page":"1271-1280","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":40,"title":["A Pandemic Lesson for Global Lung Diseases: Exacerbations Are Preventable"],"prefix":"10.1093","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9551-4677","authenticated-orcid":false,"given":"William","family":"Cookson","sequence":"first","affiliation":[{"name":"National Heart and Lung Institute, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Moffatt","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth","family":"Rapeport","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Quint","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"2026022020502769500_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2213-2600(20)30105-3","article-title":"Prevalence and attributable health burden of chronic respiratory diseases, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"8","author":"GBD Chronic Respiratory Disease Collaborators","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026022020502769500_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1513\/AnnalsATS.201703-259OC","article-title":"The economic burden of asthma in the United States, 2008-2013","volume":"15","author":"Nurmagambetov","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2026022020502769500_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/15412550601009396","article-title":"Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature","volume":"3","author":"Foster","year":"2006","journal-title":"COPD"},{"key":"2026022020502769500_bib4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.abh3986","article-title":"Uncertain effects of the pandemic on respiratory viruses","volume":"372","author":"Gomez","year":"2021","journal-title":"Science"},{"key":"2026022020502769500_bib5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.15585\/mmwr.mm6937a6","article-title":"Decreased influenza activity during the COVID-19 pandemic\u2013United States, Australia, Chile, and South Africa, 2020","volume":"69","author":"Olsen","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026022020502769500_bib6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41467-021-21157-9","article-title":"Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand","volume":"12","author":"Huang","year":"2021","journal-title":"Nat Commun"},{"key":"2026022020502769500_bib7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jinf.2020.11.010","article-title":"SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study","volume":"81","author":"Poole","year":"2020","journal-title":"J Infect"},{"key":"2026022020502769500_bib8","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1002\/ppul.25578","article-title":"Reduced pediatric urgent asthma utilization and exacerbations during the COVID-19 pandemic","volume":"56","author":"Hurst","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"2026022020502769500_bib9","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.jaip.2021.04.038","article-title":"Effect of COVID-19 on asthma exacerbation","volume":"9","author":"Salciccioli","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026022020502769500_bib10","doi-asserted-by":"crossref","first-page":"00822-2020","DOI":"10.1183\/23120541.00822-2020","article-title":"Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient\u2019s perspective","volume":"7","author":"Sykes","year":"2021","journal-title":"ERJ Open Res"},{"key":"2026022020502769500_bib11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/thoraxjnl-2020-216512","article-title":"Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data","volume":"76","author":"Shah","year":"2021","journal-title":"Thorax"},{"key":"2026022020502769500_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.alit.2021.06.001","article-title":"Impact of the COVID-19 pandemic on asthma exacerbations in children: a multi-center survey using an administrative database in Japan","volume":"70","author":"Bun","year":"2021","journal-title":"Allergol Int"},{"key":"2026022020502769500_bib13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/ppul.25335","article-title":"Frequency of asthma exacerbation in children during the coronavirus disease pandemic with strict mitigative countermeasures","volume":"56","author":"Fan","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"2026022020502769500_bib14","doi-asserted-by":"crossref","first-page":"2004493","DOI":"10.1183\/13993003.04493-2020","article-title":"Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore","volume":"57","author":"Wee","year":"2021","journal-title":"Eur Respir J"},{"key":"2026022020502769500_bib15","doi-asserted-by":"crossref","first-page":"e14423","DOI":"10.1111\/ijcp.14423","article-title":"Paediatric asthma exacerbation admissions and stringency of non-pharmaceutical interventions: results from a developing country","volume":"75","author":"Alsulaiman","year":"2021","journal-title":"Int J Clin Pract"},{"key":"2026022020502769500_bib16","doi-asserted-by":"crossref","first-page":"e000758","DOI":"10.1136\/bmjresp-2020-000758","article-title":"Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort","volume":"8","author":"de Boer","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"2026022020502769500_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12916-021-02000-w","article-title":"Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales","volume":"19","author":"Alsallakh","year":"2021","journal-title":"BMC Med"},{"key":"2026022020502769500_bib18","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.amjmed.2021.05.008","article-title":"Population decline in COPD admissions during the COVID-19 Pandemic associated with lower burden of community respiratory viral infections","volume":"134","author":"So","year":"2021","journal-title":"Am J Med"},{"key":"2026022020502769500_bib19","doi-asserted-by":"crossref","first-page":"106085","DOI":"10.1016\/j.rmed.2020.106085","article-title":"Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic","volume":"171","author":"Chan","year":"2020","journal-title":"Respir Med"},{"key":"2026022020502769500_bib20","doi-asserted-by":"crossref","first-page":"5533123","DOI":"10.1155\/2021\/5533123","article-title":"The impact of COVID-19 on hospitalised COPD exacerbations in malta","volume":"2021","author":"Farrugia","year":"2021","journal-title":"Pulm Med"},{"key":"2026022020502769500_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/thoraxjnl-2020-216083","article-title":"COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations","volume":"76","author":"Tan","year":"2021","journal-title":"Thorax"},{"key":"2026022020502769500_bib22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/ppul.25250","article-title":"Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID-19 pandemic","volume":"56","author":"Patel","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"2026022020502769500_bib23","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/rccm.202105-1137LE","article-title":"The impact of the COVID-19 pandemic on exacerbations and symptoms in bronchiectasis: a prospective study","volume":"204","author":"Crichton","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020502769500_bib24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.resinv.2021.06.007","article-title":"COVID-19 and acute exacerbation of interstitial lung disease","volume":"59","author":"Kondoh","year":"2021","journal-title":"Respir Investig"},{"key":"2026022020502769500_bib25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(21)00013-8","article-title":"Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK","volume":"9","author":"Bloom","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026022020502769500_bib26","doi-asserted-by":"crossref","first-page":"100789","DOI":"10.1016\/j.eclinm.2021.100789","article-title":"COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis","volume":"33","author":"Gerayeli","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026022020502769500_bib27","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S2589-7500(21)00017-0","article-title":"Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study","volume":"3","author":"Mansfield","year":"2021","journal-title":"Lancet Digit Health"},{"key":"2026022020502769500_bib28","doi-asserted-by":"crossref","first-page":"00718-2020","DOI":"10.1183\/23120541.00718-2020","article-title":"COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD","volume":"7","author":"McAuley","year":"2021","journal-title":"ERJ Open Res"},{"key":"2026022020502769500_bib29","doi-asserted-by":"crossref","first-page":"18984","DOI":"10.1073\/pnas.2006853117","article-title":"COVID-19 lockdowns cause global air pollution declines","volume":"117","author":"Venter","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026022020502769500_bib30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/archdischild-2020-321008","article-title":"Indirect effects of the COVID-19 pandemic on paediatric healthcare use and severe disease: a retrospective national cohort study","volume":"106","author":"Williams","year":"2021","journal-title":"Arch Dis Child"},{"key":"2026022020502769500_bib31","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Troeger","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2026022020502769500_bib32","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","article-title":"Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Lancet Digit Health"},{"key":"2026022020502769500_bib33","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1093\/cid\/ciaa1728","article-title":"Impact of the coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): prospective national cohort study, England","volume":"72","author":"Amin-Chowdhury","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026022020502769500_bib34","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.jinf.2020.08.020","article-title":"Decline in pneumococcal disease incidence in the time of COVID-19 in Singapore","volume":"81","author":"Lim","year":"2020","journal-title":"J Infect"},{"key":"2026022020502769500_bib35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jinf.2020.09.018","article-title":"Decline in invasive pneumococcal disease during COVID-19 pandemic in Taiwan","volume":"82","author":"Juan","year":"2021","journal-title":"J Infect"},{"key":"2026022020502769500_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijid.2021.08.060","article-title":"The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained","volume":"111","author":"Dirkx","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2026022020502769500_bib37","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1111\/ajt.16049","article-title":"Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021","volume":"21","author":"Olsen","year":"2021","journal-title":"Am J Transplant"},{"key":"2026022020502769500_bib38","doi-asserted-by":"crossref","first-page":"100112","DOI":"10.1016\/j.lanepe.2021.100112","article-title":"Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January\u2013September 2020: analysis of national surveillance data","volume":"6","author":"Oh","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"2026022020502769500_bib39","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.3201\/eid2711.211565","article-title":"Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo, Japan","volume":"27","author":"Ujiie","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2026022020502769500_bib40","doi-asserted-by":"crossref","first-page":"e2829","DOI":"10.1093\/cid\/ciaa1906","article-title":"The interseasonal resurgence of respiratory syncytial virus in Australian children following the reduction of coronavirus disease 2019-related public health measures","volume":"73","author":"Foley","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026022020502769500_bib41","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM196612082752301","article-title":"Rhinovirus infections in an industrial population. I. The occurrence of illness","volume":"275","author":"Gwaltney","year":"1966","journal-title":"NEngl J Med"},{"key":"2026022020502769500_bib42","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/bmj.310.6989.1225","article-title":"Community study of role of viral infections in exacerbations of asthma in 9-11 year old children","volume":"310","author":"Johnston","year":"1995","journal-title":"BMJ"},{"key":"2026022020502769500_bib43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/bmj.307.6910.982","article-title":"Respiratory viruses and exacerbations of asthma in adults","volume":"307","author":"Nicholson","year":"1993","journal-title":"BMJ"},{"key":"2026022020502769500_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MCP.0b013e3282f4a99f","article-title":"Viral infections in patients with chronic obstructive pulmonary disease","volume":"14","author":"Varkey","year":"2008","journal-title":"Curr Opin Pulm Med"},{"key":"2026022020502769500_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1513\/pats.2306030","article-title":"Role of viruses in exacerbations of chronic obstructive pulmonary disease","volume":"1","author":"Wedzicha","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"2026022020502769500_bib46","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1164\/ajrccm.164.9.2105011","article-title":"Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease","volume":"164","author":"Seemungal","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020502769500_bib47","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1513\/pats.200706-064TH","article-title":"The similarities and differences of epidemic cycles of chronic obstructive pulmonary disease and asthma exacerbations","volume":"4","author":"Johnston","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"2026022020502769500_bib48","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJM198412273112602","article-title":"Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis","volume":"311","author":"Wang","year":"1984","journal-title":"N Engl J Med"},{"key":"2026022020502769500_bib49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jcf.2007.12.002","article-title":"The role of respiratory viruses in cystic fibrosis","volume":"7","author":"Wat","year":"2008","journal-title":"J Cyst Fibros"},{"key":"2026022020502769500_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/00365548.2012.708942","article-title":"Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients","volume":"45","author":"Hoek","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"2026022020502769500_bib51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jcv.2014.02.005","article-title":"Virus and cystic fibrosis: rhinoviruses are associated with exacerbations in adult patients","volume":"60","author":"Goffard","year":"2014","journal-title":"J Clin Virol"},{"key":"2026022020502769500_bib52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/17476348.2017.1288102","article-title":"The diagnosis and management of respiratory viral infections in cystic fibrosis","volume":"11","author":"Flight","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"2026022020502769500_bib53","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/archdischild-2013-305147","article-title":"Respiratory viruses in exacerbations of non-cystic fibrosis bronchiectasis in children","volume":"99","author":"Kapur","year":"2014","journal-title":"Arch Dis Child"},{"key":"2026022020502769500_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.chom.2010.03.004","article-title":"A pathobiont of the microbiota balances host colonization and intestinal inflammation","volume":"7","author":"Chow","year":"2010","journal-title":"Cell Host Microbe"},{"key":"2026022020502769500_bib55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"2026022020502769500_bib56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1017\/S0950268800050196","article-title":"Transmission of Neisseria meningitidis among asymptomatic military recruits and antibody analysis","volume":"109","author":"Caugant","year":"1992","journal-title":"Epidemiol Infect"},{"key":"2026022020502769500_bib57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.15172\/pneu.2015.6\/520","article-title":"A review of the role of Haemophilus influenzae in community-acquired pneumonia","volume":"6","author":"Slack","year":"2015","journal-title":"Pneumonia (Nathan)"},{"key":"2026022020502769500_bib58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMoa012561","article-title":"New strains of bacteria and exacerbations of chronic obstructive pulmonary disease","volume":"347","author":"Sethi","year":"2002","journal-title":"N Engl J Med"},{"key":"2026022020502769500_bib59","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa052632","article-title":"Childhood asthma after bacterial colonization of the airway in neonates","volume":"357","author":"Bisgaard","year":"2007","journal-title":"N Engl J Med"},{"key":"2026022020502769500_bib60","doi-asserted-by":"crossref","first-page":"e8578","DOI":"10.1371\/journal.pone.0008578","article-title":"Disordered microbial communities in asthmatic airways","volume":"5","author":"Hilty","year":"2010","journal-title":"PLoS One"},{"key":"2026022020502769500_bib61","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jaci.2010.10.048","article-title":"Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma","volume":"127","author":"Huang","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020502769500_bib62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrmicro.2017.14","article-title":"The microbiota of the respiratory tract: gatekeeper to respiratory health","volume":"15","author":"Man","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"2026022020502769500_bib63","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/cea.13444","article-title":"The crosstalk between microbiome and asthma: exploring associations and challenges","volume":"49","author":"Abdel-Aziz","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"2026022020502769500_bib64","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jaci.2015.05.044","article-title":"The airway microbiome in patients with severe asthma: associations with disease features and severity","volume":"136","author":"Huang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020502769500_bib65","doi-asserted-by":"crossref","first-page":"e0152724","DOI":"10.1371\/journal.pone.0152724","article-title":"Airway microbiota in severe asthma and relationship to asthma severity and phenotypes","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"2026022020502769500_bib66","doi-asserted-by":"crossref","first-page":"e46803","DOI":"10.1371\/journal.pone.0046803","article-title":"Upper airways microbiota in antibiotic-na\u00efve wheezing and healthy infants from the tropics of rural Ecuador","volume":"7","author":"Cardenas","year":"2012","journal-title":"PLoS One"},{"key":"2026022020502769500_bib67","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.3389\/fimmu.2018.02640","article-title":"Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia","volume":"9","author":"Hanada","year":"2018","journal-title":"Front Immunol"},{"key":"2026022020502769500_bib68","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/INF.0b013e3181b6d7ec","article-title":"Microbial interactions in the respiratory tract","volume":"28","author":"Murphy","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"2026022020502769500_bib69","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.qco.0000224815.89363.15","article-title":"The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease","volume":"19","author":"Murphy","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"2026022020502769500_bib70","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1378\/chest.129.2.317","article-title":"Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD","volume":"129","author":"Wilkinson","year":"2006","journal-title":"Chest"},{"key":"2026022020502769500_bib71","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jaci.2014.02.030","article-title":"Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations","volume":"133","author":"Kloepfer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020502769500_bib72","first-page":"1119","article-title":"Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae.","volume":"9","author":"Finney","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026022020502769500_bib73","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"2026022020502769500_bib74","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhin.2020.07.023","article-title":"Public health measures during COVID-19 pandemic reduced hospital admissions for community respiratory viral infections","volume":"106","author":"Tan","year":"2020","journal-title":"J Hosp Infect"},{"key":"2026022020502769500_bib75","first-page":"ciab1014","article-title":"Decline in pneumococcal disease in young children during the COVID-19 pandemic in Israel associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal carriage: a prospective cohort study","volume":"XXX","author":"Danino","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026022020502769500_bib76","doi-asserted-by":"crossref","first-page":"103538","DOI":"10.1016\/j.ebiom.2021.103538","article-title":"Airway microbial communities, smoking and asthma in a general population sample","volume":"71","author":"Turek","year":"2021","journal-title":"EBioMedicine"},{"key":"2026022020502769500_bib77","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-immunol-093019-112348","article-title":"Control of immunity by the microbiota","volume":"39","author":"Ansaldo","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"2026022020502769500_bib78","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3389\/fimmu.2019.01203","article-title":"Commensal bacteria: an emerging player in defense against respiratory pathogens","volume":"10","author":"Khan","year":"2019","journal-title":"Front Immunol"},{"key":"2026022020502769500_bib79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrmicro.2017.122","article-title":"New opportunities for managing acute and chronic lung infections","volume":"16","author":"Cookson","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"2026022020502769500_bib80","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1183\/13993003.00405-2015","article-title":"Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma","volume":"47","author":"Simpson","year":"2016","journal-title":"Eur Respir J"},{"key":"2026022020502769500_bib81","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1164\/rccm.201810-1944CI","article-title":"Role of biologics in asthma","volume":"199","author":"McGregor","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020502769500_bib82","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"2026022020502769500_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arbres.2020.06.007","article-title":"Biologic therapy in COVID-19","volume":"57","author":"Gonz\u00e1lez-Gay","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"2026022020502769500_bib84","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.anai.2021.03.015","article-title":"Clinical and economic burden of severe asthma among US patients treated with biologic therapies","volume":"127","author":"Reibman","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026022020502769500_bib85","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S2213-2600(20)30400-8","article-title":"Reducing the burden of asthma: time to set research and clinical priorities","volume":"8","author":"Beasley","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026022020502769500_bib86","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"2026022020502769500_bib87","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/CVI.00089-15","article-title":"Vaccines for nontypeable Haemophilus influenzae: the future is now","volume":"22","author":"Murphy","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"2026022020502769500_bib88","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.abg2025","article-title":"A paradigm shift to combat indoor respiratory infection","volume":"372","author":"Morawska","year":"2021","journal-title":"Science"},{"key":"2026022020502769500_bib89","doi-asserted-by":"crossref","first-page":"148ra116","DOI":"10.1126\/scitranslmed.3004129","article-title":"Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing","volume":"4","author":"Snitkin","year":"2012","journal-title":"Sci Transl Med"},{"key":"2026022020502769500_bib90","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/0140-6736(90)92571-X","article-title":"Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis","volume":"336","author":"LiPuma","year":"1990","journal-title":"Lancet"},{"key":"2026022020502769500_bib91","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(96)05169-0","article-title":"Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic","volume":"348","author":"Cheng","year":"1996","journal-title":"Lancet"},{"key":"2026022020502769500_bib92","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(13)60632-7","article-title":"Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study","volume":"381","author":"Bryant","year":"2013","journal-title":"Lancet"},{"key":"2026022020502769500_bib93","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1126\/science.aaf8156","article-title":"Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.","volume":"354","author":"Bryant","year":"2016","journal-title":"Science"},{"key":"2026022020502769500_bib94","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/676882","article-title":"Infection prevention and control guideline for cystic fibrosis: 2013 update","volume":"35","author":"Saiman","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026022020502769500_bib95","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S1473-3099(20)30653-8","article-title":"BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial","volume":"21","author":"Prentice","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2026022020502769500_bib96","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","article-title":"Activate: Randomized clinical trial of BCG vaccination against infection in the elderly","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell"},{"key":"2026022020502769500_bib97","doi-asserted-by":"crossref","first-page":"f6471","DOI":"10.1136\/bmj.f6471","article-title":"Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis","volume":"347","author":"Azad","year":"2013","journal-title":"BMJ"},{"key":"2026022020502769500_bib98","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0092-8674(89)90688-0","article-title":"The major human rhinovirus receptor is ICAM-1","volume":"56","author":"Greve","year":"1989","journal-title":"Cell"},{"key":"2026022020502769500_bib99","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1073\/pnas.91.5.1839","article-title":"Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus","volume":"91","author":"Hofer","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026022020502769500_bib100","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.201303-0498OC","article-title":"Human rhinovirus species C infection in young children with acute wheeze is associated with increased acute respiratory hospital admissions","volume":"188","author":"Cox","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020502769500_bib101","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.1073\/pnas.1921640117","article-title":"Cryo-EM structure of rhinovirus C15a bound to its cadherin-related protein 3 receptor","volume":"117","author":"Sun","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026022020502769500_bib102","doi-asserted-by":"crossref","first-page":"e1003520","DOI":"10.1371\/journal.ppat.1003520","article-title":"An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation","volume":"9","author":"Traub","year":"2013","journal-title":"PLoS Pathog"},{"key":"2026022020502769500_bib103","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrmicro3475","article-title":"Broad-spectrum antivirals against viral fusion","volume":"13","author":"Vigant","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"2026022020502769500_bib104","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa0906312","article-title":"A large-scale, consortium-based genomewide association study of asthma","volume":"363","author":"Moffatt","year":"2010","journal-title":"N Engl J Med"},{"key":"2026022020502769500_bib105","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJMoa1211592","article-title":"Rhinovirus wheezing illness and genetic risk of childhood-onset asthma","volume":"368","author":"Cal\u0131\u015fkan","year":"2013","journal-title":"N Engl J Med"},{"key":"2026022020502769500_bib106","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1164\/rccm.201803-0438OC","article-title":"The ORMDL3 asthma gene regulates ICAM1 and has multiple effects on cellular inflammation","volume":"199","author":"Zhang","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020502769500_bib107","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ng.2830","article-title":"A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations","volume":"46","author":"B\u00f8nnelykke","year":"2014","journal-title":"Nat Genet"},{"key":"2026022020502769500_bib108","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1073\/pnas.1421178112","article-title":"Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication","volume":"112","author":"Bochkov","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026022020502769500_bib109","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/CMR.00077-12","article-title":"Human rhinoviruses","volume":"26","author":"Jacobs","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"2026022020502769500_bib110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1086\/525542","article-title":"Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections","volume":"197","author":"Peltola","year":"2008","journal-title":"J Infect Dis"},{"key":"2026022020502769500_bib111","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jaci.2010.04.010","article-title":"Analysis of the complete genome sequences of human rhinovirus","volume":"125","author":"Palmenberg","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020502769500_bib112","doi-asserted-by":"crossref","first-page":"12838","DOI":"10.1038\/ncomms12838","article-title":"A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques","volume":"7","author":"Lee","year":"2016","journal-title":"Nat Commun"},{"key":"2026022020502769500_bib113","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/microbiolspec.AID-0022-2014","article-title":"Dengue antibody-dependent enhancement: knowns and unknowns","volume":"2","author":"Halstead","year":"2014","journal-title":"Microbiol Spectr"},{"key":"2026022020502769500_bib114","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"NPJ Vaccines"},{"key":"2026022020502769500_bib115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2147\/JEP.S255211","article-title":"Experimental antiviral therapeutic studies for human rhinovirus infections","volume":"13","author":"Coultas","year":"2021","journal-title":"J Exp Pharmacol"},{"key":"2026022020502769500_bib116","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2021.09.009","article-title":"Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses","volume":"564","author":"Wang","year":"2021","journal-title":"Virology"},{"key":"2026022020502769500_bib117","doi-asserted-by":"crossref","first-page":"eaax5866","DOI":"10.1126\/scitranslmed.aax5866","article-title":"Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia","volume":"11","author":"Toots","year":"2019","journal-title":"Sci Transl Med"},{"key":"2026022020502769500_bib118","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"2026022020502769500_bib119","doi-asserted-by":"crossref","first-page":"e2163","DOI":"10.1002\/rmv.2163","article-title":"Azithromycin in viral infections","volume":"31","author":"Oliver","year":"2021","journal-title":"Rev Med Virol"},{"key":"2026022020502769500_bib120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmjebm-2020-111447","article-title":"COVID-19 clinical trials: see it big and keep it simple","volume":"26","author":"Saesen","year":"2020","journal-title":"BMJ Evid Based Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/205\/11\/1271\/67009940\/ajrccm_205_11_1271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/205\/11\/1271\/67009940\/ajrccm_205_11_1271.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:50:47Z","timestamp":1771638647000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/205\/11\/1271\/8491941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":120,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,6,1]]},"published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202110-2389ci","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6]]},"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"2021-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}